Exact Sciences
EXAS
#1907
Rank
NZ$14.19 B
Marketcap
$76.42
Share price
3.42%
Change (1 day)
-28.27%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.66. In 2022 the company made an earnings per share (EPS) of -$5.93 a decrease over its 2021 EPS that were of -$5.80.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.54-57.21%
2022-$5.932.31%
2021-$5.80-37.09%
2020-$9.22674.65%
2019-$1.19-50.69%
2018-$2.4144%
2017-$1.68-39.39%
2016-$2.77-2.94%
2015-$2.8537.1%
2014-$2.0879.71%
2013-$1.16-21.59%
2012-$1.4762.96%
2011-$0.9092.86%
2010-$0.47-3.45%
2009-$0.49-19.44%
2008-$0.60-18.18%
2007-$0.74-10.2%
2006-$0.82-10.91%
2005-$0.92-24.66%
2004-$1.22-51.33%
2003-$2.51-7.41%
2002-$2.7111.72%
2001-$2.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.09 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.57-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.67-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$85.30 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.33-300.57%๐Ÿ‡ซ๐Ÿ‡ท France